Middleton & Co Inc MA raised its stake in shares of Danaher Corporation (NYSE:DHR) by 8.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 159,944 shares of the conglomerate’s stock after buying an additional 11,810 shares during the quarter. Danaher comprises about 2.5% of Middleton & Co Inc MA’s investment portfolio, making the stock its 5th biggest position. Middleton & Co Inc MA’s holdings in Danaher were worth $13,720,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in the business. Burney Co. raised its position in shares of Danaher by 2.9% in the 1st quarter. Burney Co. now owns 21,365 shares of the conglomerate’s stock worth $1,827,000 after buying an additional 596 shares during the period. Boston Private Wealth LLC raised its position in Danaher by 0.7% in the first quarter. Boston Private Wealth LLC now owns 196,718 shares of the conglomerate’s stock valued at $16,826,000 after purchasing an additional 1,400 shares during the period. ClariVest Asset Management LLC purchased a new position in Danaher in the first quarter valued at about $157,000. Exchange Capital Management Inc. acquired a new stake in shares of Danaher during the first quarter valued at about $210,000. Finally, Municipal Employees Retirement System of Michigan grew its stake in Danaher by 0.9% in the first quarter. Municipal Employees Retirement System of Michigan now owns 19,640 shares of the conglomerate’s stock worth $1,680,000 after purchasing an additional 180 shares in the last quarter. Hedge funds and other institutional investors own 76.32% of the company’s stock.
Danaher Corporation (NYSE DHR) traded down $1.00 during midday trading on Monday, reaching $92.82. 2,773,358 shares of the company were exchanged, compared to its average volume of 2,633,946. The company has a market capitalization of $64,570.00, a PE ratio of 24.12, a P/E/G ratio of 2.23 and a beta of 1.02. Danaher Corporation has a twelve month low of $76.27 and a twelve month high of $94.82. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43.
Danaher (NYSE:DHR) last posted its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.05. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The business had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. During the same quarter in the previous year, the firm posted $0.87 earnings per share. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. equities analysts predict that Danaher Corporation will post 3.99 EPS for the current year.
A number of research firms have recently weighed in on DHR. Goldman Sachs Group reaffirmed a “neutral” rating and set a $83.00 price target on shares of Danaher in a report on Tuesday, September 26th. Credit Suisse Group lifted their price target on shares of Danaher from $93.00 to $96.00 and gave the stock an “outperform” rating in a research report on Friday, October 20th. J P Morgan Chase & Co restated an “overweight” rating and issued a $95.00 price target on shares of Danaher in a research report on Friday, September 8th. Robert W. Baird lifted their price objective on shares of Danaher from $87.00 to $97.00 and gave the stock an “outperform” rating in a research report on Friday, October 20th. Finally, Morgan Stanley lifted their price objective on shares of Danaher from $95.00 to $98.00 and gave the stock an “overweight” rating in a research report on Friday, October 20th. One analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $93.31.
In other news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the company’s stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the transaction, the chief executive officer now directly owns 271,737 shares in the company, valued at $25,173,715.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Donald J. Ehrlich sold 10,578 shares of the stock in a transaction that occurred on Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total transaction of $960,693.96. Following the completion of the transaction, the director now owns 104,621 shares in the company, valued at $9,501,679.22. The disclosure for this sale can be found here. Insiders have sold 273,810 shares of company stock worth $25,218,813 over the last quarter. 12.20% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Danaher Corporation (DHR) is Middleton & Co Inc MA’s 5th Largest Position” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2017/12/04/middleton-co-inc-ma-boosts-position-in-danaher-corporation-dhr.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.